bismuth subgallate

2,7-dihydroxy-1,3,2-benzodioxabismole-5-carboxylic acid

CAS: 99-26-3 C7 H5 Bi O6 MW: 394.09245000

Identification

Namebismuth subgallate
CAS Number99-26-3
EINECS202-742-2
FDA UNIIYIW503MI7V
Molecular FormulaC7 H5 Bi O6
Molecular Weight394.09245000
MDL NumberMFCD20441998

Regulatory

Physical Properties

Assay 95.00 to 100.00
Food Chemicals Codex Listed No
Flash Point 32.00 °F. TCC ( 0.00 °C. ) (est)
Soluble in water, 2568 mg/L @ 25 °C (est)

Cosmetic Information

CosIngcosmetic data
Cosmetic Usesskin conditioning

No sensory data available

Safety Information

Preferred SDSView
Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categorycosmetic ingredient for skin conditioning
Recommendation for bismuth subgallate usage levels up tonot for fragrance use.
Recommendation for bismuth subgallate flavor usage levels up tonot for flavor use.

American International Chemical, Inc.

Consistent sources

North American supplier for globally sourced ingredients.

View All Website (800) 238-0001 info@aicma.com

Glentham Life Sciences Ltd

The Chemical, Biochemical & Research Essentials Supplier

Glentham Life Sciences is a supplier of fine chemicals and raw materials with warehousing, laboratories and packaging facilities in the UK.

View All Website +44 (0) 1225 667798 info@glentham.com

Potential Uses

None Found

Natural Occurrence

not found in nature

Synonyms

basisches wismutgallat 1,3,2- benzodioxabismole-5-carboxylic acid, 2,7-dihydroxy- bismuth gallate basic dermatol 2,7- dihydroxy-1,3,2-benzodioxabismole-5-carboxylic acid gallic acid bismuth basic salt 4- hydroxy-1,3,2lambda2-benzodioxabismole-6-carboxylic acid;hydrate wismutgallathydroxid PubMed: [Clinical study on topical bismuth subgallate/borneol (Suile) dressing for treatment of diabetic foot ulcers]. PubMed: Bismuth subgallate as a topical haemostatic agent at the palatal wounds: a histologic study in dogs. PubMed: In vitro antibacterial activity and cytocompatibility of bismuth doped micro-arc oxidized titanium. PubMed: Bismuth subgallate as a topical hemostatic agent at palatal donor sites. PubMed: Effect of bismuth subgallate (a hemostatic agent) on bone repair; a histologic, radiographic and histomorphometric study in rats. PubMed: Bismuth subgallate/borneol (suile) is superior to bacitracin in the human forearm biopsy model for acute wound healing. PubMed: Evaluation of bismuth subgallate and adrenaline paste as haemostat in tonsillectomy bleeding. PubMed: [Topic usage of bismuth subgallate as a hemostatic in tonsillectomy]. PubMed: The effect of bismuth subgallate as haemostatic agent in tonsillectomy. PubMed: Effect of bismuth subgallate on nitric oxide and prostaglandin E2 production by macrophages. PubMed: Synergistic effect of bismuth subgallate and borneol, the major components of Sulbogin, on the healing of skin wound. PubMed: Effect of bismuth subgallate (local hemostatic agent) on wound healing in rats. Histological and histometric findings. PubMed: [Mastu S - a new antihemorrhoidal cream for pregnant women]. PubMed: Bismuth subgallate-epinephrine paste in adenotonsillectomies. PubMed: Respiratory difficulty following bismuth subgallate aspiration. PubMed: Does bismuth subgallate have haemostatic effects in tonsillectomy? PubMed: Avoidance of primary post-tonsillectomy hemorrhage in a teaching program. PubMed: [Comment on the contribution by J. Strutz. Bismuth gallate in wound management]. PubMed: [Bismuth gallate in wound treatment]. PubMed: Effect of bismuth salts on systemic and mucosal immune responses to orally administered cholera toxin. PubMed: The influence of bismuth subgallate and adrenaline paste upon operating time and operative blood loss in tonsillectomy. PubMed: Bismuth subgallate--its role in tonsillectomy. PubMed: Inhibitory action of amyloid precursor protein against human Hageman factor (factor XII). PubMed: Electrocautery-induced ignition of tonsillar packing. PubMed: Bismuth subgallate: a safe means to a faster adenotonsillectomy. PubMed: Therapeutics used to alleviate peptic ulcers inhibit H. pylori receptor binding in vitro. PubMed: Encephalopathy associated with bismuth subgallate therapy. PubMed: Inhibition of the activation of hageman factor (factor XII) by eosinophils and eosinophilic constituents. PubMed: Pulmonary sequelae of intraparenchymal bismuth subgallate. PubMed: Bismuth absorption from 205Bi-labelled pharmaceutical bismuth compounds used in the treatment of peptic ulcer disease. PubMed: Inhibition of the activation of Hageman factor (factor XII) by human vascular endothelial cell culture supernates. PubMed: [Effect of meals on resorption of bismuth from an oral bismuth gallate/bismuth nitrate preparation]. PubMed: Bismuth therapy in gastrointestinal diseases. PubMed: Pitfall-to-avoid pharyngeal opacities caused by bismuth subgallate. PubMed: The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori. PubMed: [Myoclonic encephalopathy caused by bismuth salts. Efficacy of treatment with dimercaprol]. PubMed: Myoclonic encephalopathy due to bismuth salts: treatment with dimercaprol and analysis of CSF transmitters. PubMed: Adenotonsillectomy. A safe outpatient procedure. PubMed: Activation of Hageman factor (factor XII) by bismuth subgallate, a hemostatic agent. PubMed: Paul Langerhans' death centennial, July 20, 1988. PubMed: Drug samples. A conflict of interest? PubMed: Bibliography of secondary sources on the history of dermatology. II. Obituaries and biographies in English journals supplemented through 1985. PubMed: [Persistent hallucinatory symptoms in a case of bismuth encephalopathy]. PubMed: Umbilical care and cord separation. PubMed: Effect of antidiarrheal and antimotility drugs on ileal excreta. PubMed: Letter: Mental illness or metal illness? Bismuth subgallate. PubMed: Adverse effects of bismuth subgallate. A further report from the Australian Drug Evaluation Committee. PubMed: Editorial: Bismuth subgallate poisoning. PubMed: Mental illness or metal illness? Bismuth subgallate. PubMed: Correspondence: Bismuth subgallate as an effective means for the control of ileostomy odor: a double blind study. PubMed: Reversible encephalopathy possibly associated with bismuth subgallate ingestion. PubMed: [Study of dermatol].